Literature DB >> 21643977

Decreased expression of lysosomal alpha-galactosiase A gene in sporadic Parkinson's disease.

Guanghua Wu1, Jian Huang, Xungang Feng, Aimei Zhang, Jifeng Li, Shuchao Pang, Kejin Gu, Haixin Dong, Junping Zhang, Huijie Gao, Bo Yan.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disease. To date, the causal genes and variants associated with sporadic PD are largely unknown. Accumulating evidence demonstrates that autophagy delivers alpha-syncuclein proteins to lysosome for degradation and dysfunctional autophagy is involved in the PD pathogenesis. We have previously screened a group of lysosomal hydrolases and found that alpha-galactosidase A (GLA) activity is significantly decreased in the peripheral leukocytes of sporadic PD patients. In this study, GLA transcript and protein levels were semi-quantitatively examined. The GLA transcript (P = 0.020) and protein (P = 0.027) levels in the peripheral leukocytes of sporadic PD patients were significantly decreased, compared to age- and sex-matched healthy controls. Furthermore, decreased GLA gene expression levels were strongly associated with sporadic PD (OR 3.33, 95%CI 1.17-9.52, P = 0.024). Therefore, our data suggest that insufficient GLA activity may contribute to the pathogenesis of sporadic PD. The underlying molecular mechanisms remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643977     DOI: 10.1007/s11064-011-0516-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  48 in total

Review 1.  Parkinson's disease: insights from pathways.

Authors:  Mark R Cookson; Oliver Bandmann
Journal:  Hum Mol Genet       Date:  2010-04-26       Impact factor: 6.150

Review 2.  Autophagy gone awry in neurodegenerative diseases.

Authors:  Esther Wong; Ana Maria Cuervo
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

3.  Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.

Authors:  Demetrius M Maraganore; Mariza de Andrade; Alexis Elbaz; Matthew J Farrer; John P Ioannidis; Rejko Krüger; Walter A Rocca; Nicole K Schneider; Timothy G Lesnick; Sarah J Lincoln; Mary M Hulihan; Jan O Aasly; Tetsuo Ashizawa; Marie-Christine Chartier-Harlin; Harvey Checkoway; Carlo Ferrarese; Georgios Hadjigeorgiou; Nobutaka Hattori; Hideshi Kawakami; Jean-Charles Lambert; Timothy Lynch; George D Mellick; Spiridon Papapetropoulos; Abbas Parsian; Aldo Quattrone; Olaf Riess; Eng-King Tan; Christine Van Broeckhoven
Journal:  JAMA       Date:  2006-08-09       Impact factor: 56.272

4.  Autophagosome maturation is impaired in Fabry disease.

Authors:  Marc Chévrier; Noureddine Brakch; Lesueur Céline; Damien Genty; Yasmina Ramdani; Solange Moll; Mojgan Djavaheri-Mergny; Carole Brasse-Lagnel; Annie Laquerrière Annie Laquerrière; Frédéric Barbey; Soumeya Bekri
Journal:  Autophagy       Date:  2010-07-01       Impact factor: 16.016

5.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

6.  alpha-Synuclein and Parkinson disease susceptibility.

Authors:  S Winkler; J Hagenah; S Lincoln; M Heckman; K Haugarvoll; K Lohmann-Hedrich; V Kostic; M Farrer; C Klein
Journal:  Neurology       Date:  2007-09-13       Impact factor: 9.910

Review 7.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

Review 8.  The role of glycosphingolipid metabolism in the developing brain.

Authors:  Robert K Yu; Yoshihiko Nakatani; Makoto Yanagisawa
Journal:  J Lipid Res       Date:  2008-10-09       Impact factor: 5.922

Review 9.  Lysosomal disorders: from storage to cellular damage.

Authors:  Andrea Ballabio; Volkmar Gieselmann
Journal:  Biochim Biophys Acta       Date:  2008-12-08

Review 10.  Mendelian forms of Parkinson's disease.

Authors:  Thomas Gasser
Journal:  Biochim Biophys Acta       Date:  2009-01-06
View more
  8 in total

Review 1.  Cerebrospinal fluid biomarkers in Parkinson disease.

Authors:  Lucilla Parnetti; Anna Castrioto; Davide Chiasserini; Emanuele Persichetti; Nicola Tambasco; Omar El-Agnaf; Paolo Calabresi
Journal:  Nat Rev Neurol       Date:  2013-02-19       Impact factor: 42.937

2.  The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies.

Authors:  Susana Ferreira; Alberto Ortiz; Dominique P Germain; Miguel Viana-Baptista; António Caldeira-Gomes; Marta Camprecios; Maria Fenollar-Cortés; Ángel Gallegos-Villalobos; Diego Garcia; José Antonio García-Robles; Jesús Egido; Eduardo Gutiérrez-Rivas; José Antonio Herrero; Sebastián Mas; Raluca Oancea; Paloma Péres; Luis Manuel Salazar-Martín; Jesús Solera-Garcia; Helena Alves; Scott C Garman; João Paulo Oliveira
Journal:  Mol Genet Metab       Date:  2014-11-09       Impact factor: 4.797

Review 3.  Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease.

Authors:  Ziv Gan-Or; Patrick A Dion; Guy A Rouleau
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 4.  Genes associated with Parkinson's disease: regulation of autophagy and beyond.

Authors:  Alexandra Beilina; Mark R Cookson
Journal:  J Neurochem       Date:  2015-09-03       Impact factor: 5.372

5.  Impaired Sphingolipid Hydrolase Activities in Dementia with Lewy Bodies and Multiple System Atrophy.

Authors:  T S Usenko; K A Senkevich; A I Bezrukova; G V Baydakova; K S Basharova; A S Zhuravlev; E V Gracheva; A V Kudrevatykh; I V Miliukhina; I V Krasakov; L A Khublarova; I V Fursova; D V Zakharov; A A Timofeeva; Y A Irishina; E I Palchikova; N M Zalutskaya; A K Emelyanov; E Y Zakharova; S N Pchelina
Journal:  Mol Neurobiol       Date:  2022-01-23       Impact factor: 5.590

Review 6.  Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease.

Authors:  Silvia Paciotti; Elisabetta Albi; Lucilla Parnetti; Tommaso Beccari
Journal:  J Clin Med       Date:  2020-02-21       Impact factor: 4.241

7.  Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice.

Authors:  Michael P Nelson; Tonia E Tse; Darrel B O'Quinn; Stefanie M Percival; Edgar A Jaimes; David G Warnock; John J Shacka
Journal:  Acta Neuropathol Commun       Date:  2014-02-14       Impact factor: 7.801

Review 8.  Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson's Disease.

Authors:  Srinivasa Reddy Bonam; Christine Tranchant; Sylviane Muller
Journal:  Cells       Date:  2021-12-15       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.